AI-Powered Retinal Screening: Transforming Eye Care for the Forgotten Billions

AI-Powered Retinal Screening: Transforming Eye Care for the Forgotten Billions

Retinal diseases such as diabetic retinopathy and other sight-threatening retinal conditions often progress silently, making early detection critical to preventing avoidable vision loss. However, millions of people worldwide still lack access to timely eye screening due to limitations in healthcare infrastructure, specialist availability, and geographic barriers.

This is where Artelus, the next generation of AI-powered retinal diagnostics and imaging solutions, is helping transform eye care. By combining advanced Artificial Intelligence, retinal imaging, and portable diagnostic technologies, Artelus enables faster, more accessible, and scalable retinal screening. Its solutions support healthcare professionals in identifying retinal diseases earlier, strengthening referral pathways, and extending quality eye care to underserved communities and the Forgotten Billions.

With a mission to prevent avoidable blindness through innovation, Artelus is making high-quality retinal diagnostics more accessible, affordable, and scalable across clinics, hospitals, community screening programs, and remote healthcare settings.

**Key Highlights **

i. Artificial Intelligence is helping make retinal screening faster, more accessible, and scalable.

ii. Artelus focuses on early detection of avoidable blindness through AI-powered retinal diagnostics.

iii. DRISTi AI supports diabetic retinopathy screening by analyzing fundus images and identifying retinal abnormalities.

iv. Artelus also advances glaucoma risk assessment by calculating Cup-to-Disc Ratio from a single fundus image.

v. Portable retinal imaging and OCT solutions can support clinics, hospitals, rural camps, and outreach programs.

vi. The goal is not to replace doctors, but to empower healthcare professionals with faster, reliable decision-support tools.

Introduction

Vision loss caused by retinal diseases is often preventable when detected early. However, millions of people, especially in underserved and remote communities, do not receive timely eye screening. Conditions such as diabetic retinopathy, glaucoma, age-related macular degeneration, and other retinal abnormalities may progress silently before symptoms become noticeable.

This is where Artelus is creating meaningful impact.

Artelus is using Artificial Intelligence, retinal imaging, and portable diagnostic technologies to make eye care more accessible, affordable, and scalable. Its mission is focused on bringing advanced healthcare technology to the “Forgotten Billions” by enabling early detection and timely referral.

**Why Early Retinal Screening Matters **

The retina can reveal important signs of eye and systemic health. In diabetes, high blood sugar can damage retinal blood vessels, leading to diabetic retinopathy. In glaucoma, changes in the optic disc and Cup-to-Disc Ratio can indicate risk. Many of these conditions may not show early symptoms, making regular screening essential. Traditional screening often requires trained specialists, advanced equipment, and centralized facilities. This creates barriers in rural areas, community health programs, and high-volume screening environments. AI-powered screening helps bridge this gap by supporting faster image analysis, early risk identification, and timely clinical action.

Artelus and AI in Diabetic Retinopathy Screening

Diabetic retinopathy is one of the leading causes of preventable vision loss. Artelus’ DRISTi AI is designed to analyze retinal fundus images and detect signs of diabetic retinopathy with speed and accuracy.

By identifying early retinal changes, DRISTi AI helps healthcare providers screen more patients efficiently and refer those at risk for further evaluation. Artelus’ blog also highlights its impact in large-scale screening, including over 203,000 patients screened and around 48,000 DR-positive cases identified.

Portable Imaging for Real-World Eye Care

For eye screening to reach more people, technology must be practical in real-world clinical settings. Artelus combines AI with portable retinal imaging and OCT solutions to support screening in clinics, hospitals, outreach camps, rural areas, and bedside care. Portable devices help reduce dependency on large infrastructure while maintaining reliable imaging quality. This is especially valuable for community screening programs, pediatric or geriatric patients, and locations where access to specialists is limited.

Supporting Doctors, Not Replacing Them

AI in eye care works best as a clinical support tool. It helps doctors and healthcare teams by reducing manual workload, improving screening efficiency, and highlighting patients who need urgent attention.

The final diagnosis and treatment decisions remain with qualified healthcare professionals. Artelus’ role is to strengthen clinical workflows and help more patients receive timely care.

The Future of AI-Powered Eye Care

The future of ophthalmology will be shaped by a combination of clinical expertise, AI-driven insights, portable imaging, and scalable screening models. As retinal diseases continue to increase globally, early detection will become even more important.

Artelus is contributing to this future by building solutions that are accurate, affordable, portable, and designed for large-scale impact.

Conclusion

Preventing avoidable blindness begins with early screening. Through DRISTi AI, fundus imaging, OCT solutions, and AI-based retinal analysis, Artelus is helping make quality eye care more accessible to patients who need it most.

By combining innovation with purpose, Artelus is advancing a future where timely retinal screening is not limited by geography, cost, or infrastructure.

Artelus: Applying Deep Learning technology to bring healthcare to the Forgotten Billions. _ To learn more about Artelus' AI-powered retinal screening solutions or to schedule a meeting, contact us at: contact@artelus.com __